C12Y 207/01095
Kanamycin kinase , i.e. neomycin-kanamycin phosphotransferase
Official title: Kanamycin kinase (2.7.1.95), i.e. neomycin-kanamycin phosphotransferase
C12Y207/01095 (Kanamycin kinase , i.e. neomycin-kanamycin phosphotransferase) appears on 27 US grants and 38 published applications in this corpus.
Search patents in C12Y- Granted patents
- 27
- Published applications
- 38
- Assignees
- 19
- Inventors
- 56
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 3 |
| 2007 | 1 | 2 |
| 2008 | 1 | 8 |
| 2009 | 1 | 3 |
| 2010 | 3 | 0 |
| 2011 | 2 | 3 |
| 2012 | 3 | 1 |
| 2013 | 1 | 1 |
| 2014 | 1 | 3 |
| 2015 | 3 | 2 |
| 2016 | 2 | 2 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CYP76AD1-beta clade polynucleotides, polypeptides, and methods for producing betalains20 Jan 2026US 12,529,083 B2Rada Research and Development Co. Ltd.
- CYP76AD1-beta clade polynucleotides, polypeptides, and uses thereof19 Mar 2024US 11,932,887 B2Yeda Research and Development Co. Ltd.
- CYP76AD1-beta clade polynucleotides, polypeptides, and uses thereof8 Sep 2020US 10,767,201 B2Yeda Research and Development Co. Ltd.
- Methods and compositions for generating stable transfected cells11 Jun 2019US 10,316,335 B2MaxCyte, Inc.
- Albumin fusion proteins29 Mar 2016US 9,296,809 B2Human Genome Sciences, Inc.
- Compositions and methods for enhancing drug resistance in cells10 Sep 2026US 2026/0265712 A1Medici Therapeutics, Inc.
- Cyp76ad1-beta clade polynucleotides, polypeptides, and uses thereof30 Apr 2026US 2026/0117269 A1Yeda Research and Development Co. Ltd.
- Genetically modified organism for recombinant protein production1 May 2025US 2025/0136691 A1Plantibodies Corporation
- Cyp76ad1-beta clade polynucleotides, polypeptides, and uses thereof8 Aug 2024US 2024/0263202 A1Yeda Research and Development Co. Ltd.
- Materials and methods for improved phosphotransferases13 Jun 2024US 2024/0191215 A1Janssen Biotech, Inc.
Most cited
By later US patents
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Albumin fusion proteins96US 7,592,010 B2Delta Biotechnology Limited · 2009
- Antisense gene systems of pollination control for hybrid seed production62US 5,356,799 APioneer Hi-Bred International, Inc. · 1994
- Albumin fusion proteins34US 7,847,079 B2Human Genome Sciences, Inc. · 2010
- Albumin fusion proteins34US 8,252,739 B2Human Genome Sciences, Inc. · 2012